These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 9549491)

  • 1. Imaging axonal damage of normal-appearing white matter in multiple sclerosis.
    Fu L; Matthews PM; De Stefano N; Worsley KJ; Narayanan S; Francis GS; Antel JP; Wolfson C; Arnold DL
    Brain; 1998 Jan; 121 ( Pt 1)():103-13. PubMed ID: 9549491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy.
    Ruiz-Peña JL; Piñero P; Sellers G; Argente J; Casado A; Foronda J; Uclés A; Izquierdo G
    BMC Neurol; 2004 Jun; 4():8. PubMed ID: 15191618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis.
    Gadea M; Martínez-Bisbal MC; Marti-Bonmatí L; Espert R; Casanova B; Coret F; Celda B
    Brain; 2004 Jan; 127(Pt 1):89-98. PubMed ID: 14506072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
    Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
    J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.
    De Stefano N; Matthews PM; Fu L; Narayanan S; Stanley J; Francis GS; Antel JP; Arnold DL
    Brain; 1998 Aug; 121 ( Pt 8)():1469-77. PubMed ID: 9712009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
    Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW
    Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS.
    Suhy J; Rooney WD; Goodkin DE; Capizzano AA; Soher BJ; Maudsley AA; Waubant E; Andersson PB; Weiner MW
    Mult Scler; 2000 Jun; 6(3):148-55. PubMed ID: 10871825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis.
    De Stefano N; Narayanan S; Matthews PM; Francis GS; Antel JP; Arnold DL
    Brain; 1999 Oct; 122 ( Pt 10)():1933-9. PubMed ID: 10506094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
    Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
    Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
    He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O
    Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.
    De Stefano N; Narayanan S; Francis GS; Arnaoutelis R; Tartaglia MC; Antel JP; Matthews PM; Arnold DL
    Arch Neurol; 2001 Jan; 58(1):65-70. PubMed ID: 11176938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.
    Pascual AM; Martínez-Bisbal MC; Boscá I; Valero C; Coret F; Martínez-Granados B; Marti-Bonmati L; Mir A; Celda B; Casanova B
    Neurology; 2007 Jul; 69(1):63-7. PubMed ID: 17606882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
    Parry A; Corkill R; Blamire AM; Palace J; Narayanan S; Arnold D; Styles P; Matthews PM
    J Neurol; 2003 Feb; 250(2):171-8. PubMed ID: 12574947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Total brain T2-hyperintense lesion-volume and the axonal damage in the normal-appearing white matter of brainstem in early lapsing-remitting multiple sclerosis].
    Pascual-Lozano AM; Martínez-Bisbal MC; Boscá-Blasco I; Valero-Merino C; Coret-Ferrer F; Martí-Bonmatí L; Martínez-Granados B; Celda B; Casanova-Estruch B
    Rev Neurol; 2007 Oct 16-31; 45(8):468-73. PubMed ID: 17948212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistics for investigation of multimodal MR imaging data and an application to multiple sclerosis patients.
    Fu L; Wolfson C; Worsley KJ; De Stefano N; Collins DL; Narayanan S; Arnold DL
    NMR Biomed; 1996 Dec; 9(8):339-46. PubMed ID: 9176888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging.
    Kirov II; Liu S; Tal A; Wu WE; Davitz MS; Babb JS; Rusinek H; Herbert J; Gonen O
    Hum Brain Mapp; 2017 Aug; 38(8):4047-4063. PubMed ID: 28523763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient.
    De Stefano N; Matthews PM; Narayanan S; Francis GS; Antel JP; Arnold DL
    Neurology; 1997 Oct; 49(4):1138-41. PubMed ID: 9339704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis.
    Adalsteinsson E; Langer-Gould A; Homer RJ; Rao A; Sullivan EV; Lima CA; Pfefferbaum A; Atlas SW
    AJNR Am J Neuroradiol; 2003; 24(10):1941-5. PubMed ID: 14625214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis.
    Liu Z; Pardini M; Yaldizli Ö; Sethi V; Muhlert N; Wheeler-Kingshott CA; Samson RS; Miller DH; Chard DT
    Brain; 2015 May; 138(Pt 5):1239-46. PubMed ID: 25823475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.